The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine

NCT04064879 · clinicaltrials.gov ↗
NA
Phase
SUSPENDED
Status
10
Enrollment
OTHER
Sponsor class

Stopped Pending FDA approval

Conditions

Interventions

Sponsor

Neurological Associates of West Los Angeles

Collaborators